SCHEMBL3296171

SCHEMBL3296171

CCCCCCOCC(=O)O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.69
EPHX2 P34913 1/20 0.58
PAM P19021 2/20 0.53
PLA2G4B P0C869 2/20 0.51
GPR84 Q9NQS5 7/20 0.50
PPARG P37231 6/20 0.50
PPARD Q03181 6/20 0.50
PPARA Q07869 6/20 0.50
HDAC11 Q96DB2 5/20 0.50
TSHR P16473 4/20 0.50
ALDH1A1 P00352 2/20 0.50
TLR2 O60603 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
MEN1 O00255 2/20 0.50
FABP4 P15090 2/20 0.50
PTPN1 P18031 2/20 0.50
KMT2A Q03164 2/20 0.50
SLC22A6 Q4U2R8 1/20 0.50
SLC22A8 Q8TCC7 1/20 0.50
ESR1 P03372 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4651569 1.00 CES2 (0.69) CES2EPHX2PAMPLA2G4BGPR84
SCHEMBL7249862 1.00 CES2 (0.69) CES2EPHX2PAMPLA2G4BGPR84
SCHEMBL8198788 1.00 CES2 (0.69) CES2EPHX2PAMPLA2G4BGPR84
SCHEMBL501889 1.00 CES2 (0.69) CES2EPHX2PAMPLA2G4BGPR84
SCHEMBL1603697 1.00 CES2 (0.69) CES2EPHX2PAMPLA2G4BGPR84
SCHEMBL21611691 1.00 CES2 (0.69) CES2EPHX2PAMPLA2G4BGPR84
SCHEMBL7763197 1.00 CES2 (0.69) CES2EPHX2PAMPLA2G4BGPR84
SCHEMBL8626082 1.00 CES2 (0.69) CES2EPHX2PAMPLA2G4BGPR84
SCHEMBL21611665 1.00 CES2 (0.69) CES2EPHX2PAMPLA2G4BGPR84
SCHEMBL7611940 1.00 CES2 (0.69) CES2EPHX2PAMPLA2G4BGPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12577373-B2 Carbodiimide composition, curing agent composition, coating composition and resin cured product ASAHI KASEI KABUSHIKI KAISHA (JP) 2026-03-17 US disclosed
US-20230135772-A1 CARBODIIMIDE COMPOSITION, CURING AGENT COMPOSITION, COATING COMPOSITION AND RESIN CURED PRODUCT ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-05-04 US disclosed
EP-4130154-A1 CARBODIIMIDE COMPOSITION, HARDENER COMPOSITION, COATING COMPOSITION, AND CURED RESIN OBJECT Asahi Kasei Kabushiki Kaisha (JP) 2023-02-08 EP disclosed
CN-113004108-B Method for preparing acid by oxidizing alcohol or aldehyde with oxygen 中国科学院上海有机化学研究所 2022-06-07 CN disclosed
CN-113004108-A Method for preparing acid by oxidizing alcohol or aldehyde with oxygen 中国科学院上海有机化学研究所 2021-06-22 CN disclosed
CN-107176899-B Method for preparing acid by oxidizing alcohol or aldehyde with oxygen 中国科学院上海有机化学研究所 2021-04-13 CN disclosed
CN-107176899-A Method for preparing acid by oxidizing alcohol or aldehyde with oxygen 中国科学院上海有机化学研究所 2017-09-19 CN disclosed
US-9337032-B2 Method of forming pattern of semiconductor device SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-05-10 US disclosed
EP-2000126-B1 HAIR DYEING COMPOSITION KAO CORP (JP) 2015-08-19 EP disclosed
US-20150118852-A1 METHOD OF FORMING PATTERN OF SEMICONDUCTOR DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2015-04-30 US disclosed
EP-0142322-B1 CYCLOHEXANE DERIVATIVES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-03-09 EP disclosed
EP-0228788-A1 Herbicidal derivatives of substituted benzoyl-hydrazinium compounds IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1987-07-15 EP disclosed
EP-0202086-A2 Hexenoic acids IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1986-11-20 EP disclosed
EP-0201349-A2 Tetrazole derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1986-11-12 EP disclosed
EP-0201351-A2 1,3-Dioxane ethers IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1986-11-12 EP disclosed
EP-0201354-A2 2,4-Diphenyl-1,3-Dioxanes IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1986-11-12 EP disclosed
EP-0142322-A2 Cyclohexane derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1985-05-22 EP disclosed
US-4515727-A ANTIALLERGY, ANTINFLAMMATORY SYNTEX (U.S.A.) INC. (US) 1985-05-07 US disclosed
US-4484992-A SEMICONDUCTOR POWDER OF CADMIUM SULFIDE, CADMIUM SULFOSELENIDE OR TITANIUM DIOXIDE COATED WITH METAL CIBA-GEIGY CORPORATION (US) 1984-11-27 US disclosed
US-4202891-A ANOREXIGENIC AGENTS, ANTICHOLESTEROL AGENTS, INHIBITORS OF CELL GROWTH PARISH, EDWARD J. 1980-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12577373-B2 Carbodiimide composition, curing agent composition, coating composition and resin cured product CD38, PARP9, MCCC2 CES2 538/4885EPHX2 1451/4885PAM 830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.